Rick Blum is meticulous about planning, ordering, and taking the medication he is prescribed to slow the progression of ...

Millions of Americans who receive intravenous treatment for multiple sclerosis, blood diseases and rheumatologic conditions ...

Morton Village Plaza in Plainview underwent a $2 million renovation between 2023 and last year, property management said.

Levels of B-cells can help to predict the risk of disability progression independent of relapse activity in relapsing MS ...

Roche Holdings AG (OTC:RHHBY) on Tuesday released statistically significant final overall survival (OS) results from the ...

Multiple sclerosis is a chronic condition affecting ... approved the first DMT for people with PPMS. This infusion drug, ocrelizumab (Ocrevus), can also be used to treat RRMS.

by infusion or intravenously, or via subcutaneous injection – is an issue with this disease. “Poor adherence to disease-modifying drug treatment in multiple sclerosis remains a challenge in ...

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive ...

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS ... that drug needs to be administered by intravenous infusion. While it requires a clinic visit, Ocrevus only ...

Roche has been leading research into the HER2 pathway for over 30 years and is committed to improving the health, quality of ...

Option Care Health, Inc.’s OPCH share price has dipped by 5.35%, which has investors questioning if this is right time to buy.

Learn more about whether Option Care Health, Inc. or Premier, Inc. is a better investment based on AAII's A+ Investor grades, ...